rs41273619

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006218.4(PIK3CA):​c.1747-13T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0481 in 1,268,272 control chromosomes in the GnomAD database, including 1,578 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.051 ( 211 hom., cov: 32)
Exomes 𝑓: 0.048 ( 1367 hom. )

Consequence

PIK3CA
NM_006218.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.80

Publications

7 publications found
Variant links:
Genes affected
PIK3CA (HGNC:8975): (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]
PIK3CA Gene-Disease associations (from GenCC):
  • overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • megalencephaly-capillary malformation-polymicrogyria syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • vascular malformation
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 5
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-179219558-T-C is Benign according to our data. Variant chr3-179219558-T-C is described in ClinVar as Benign. ClinVar VariationId is 259959.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0557 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIK3CANM_006218.4 linkc.1747-13T>C intron_variant Intron 11 of 20 ENST00000263967.4 NP_006209.2 P42336Q4LE51
PIK3CAXM_006713658.5 linkc.1747-13T>C intron_variant Intron 11 of 20 XP_006713721.1 P42336Q4LE51

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIK3CAENST00000263967.4 linkc.1747-13T>C intron_variant Intron 11 of 20 2 NM_006218.4 ENSP00000263967.3 P42336

Frequencies

GnomAD3 genomes
AF:
0.0510
AC:
7748
AN:
151960
Hom.:
212
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0418
Gnomad AMI
AF:
0.0548
Gnomad AMR
AF:
0.0511
Gnomad ASJ
AF:
0.0869
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0116
Gnomad FIN
AF:
0.0742
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0572
Gnomad OTH
AF:
0.0699
GnomAD2 exomes
AF:
0.0469
AC:
10621
AN:
226646
AF XY:
0.0470
show subpopulations
Gnomad AFR exome
AF:
0.0426
Gnomad AMR exome
AF:
0.0379
Gnomad ASJ exome
AF:
0.0893
Gnomad EAS exome
AF:
0.0000593
Gnomad FIN exome
AF:
0.0655
Gnomad NFE exome
AF:
0.0594
Gnomad OTH exome
AF:
0.0524
GnomAD4 exome
AF:
0.0478
AC:
53307
AN:
1116194
Hom.:
1367
Cov.:
14
AF XY:
0.0471
AC XY:
26727
AN XY:
567718
show subpopulations
African (AFR)
AF:
0.0410
AC:
1066
AN:
26012
American (AMR)
AF:
0.0394
AC:
1549
AN:
39272
Ashkenazi Jewish (ASJ)
AF:
0.0862
AC:
1968
AN:
22842
East Asian (EAS)
AF:
0.0000529
AC:
2
AN:
37776
South Asian (SAS)
AF:
0.0122
AC:
925
AN:
75596
European-Finnish (FIN)
AF:
0.0609
AC:
3191
AN:
52380
Middle Eastern (MID)
AF:
0.0483
AC:
241
AN:
4990
European-Non Finnish (NFE)
AF:
0.0518
AC:
41939
AN:
808950
Other (OTH)
AF:
0.0501
AC:
2426
AN:
48376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
2487
4974
7461
9948
12435
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1250
2500
3750
5000
6250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0510
AC:
7749
AN:
152078
Hom.:
211
Cov.:
32
AF XY:
0.0508
AC XY:
3774
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.0417
AC:
1733
AN:
41540
American (AMR)
AF:
0.0510
AC:
779
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.0869
AC:
301
AN:
3462
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5180
South Asian (SAS)
AF:
0.0116
AC:
56
AN:
4822
European-Finnish (FIN)
AF:
0.0742
AC:
786
AN:
10594
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0572
AC:
3883
AN:
67896
Other (OTH)
AF:
0.0687
AC:
145
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
368
736
1105
1473
1841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0575
Hom.:
82
Bravo
AF:
0.0506

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 06, 2018
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Jul 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Cowden syndrome 5 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cowden syndrome Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
11
DANN
Benign
0.59
PhyloP100
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41273619; hg19: chr3-178937346; API